• Firdapse and Ruzurgi (Amifampridine)

  Firdapse approval in Canada

  Posted by Price Wooldridge on July 13, 2020 at 9:50 am

  Catalyst Pharmaceuticals’ LEMS medication, Firdapse (amifampridine), is nearing approval for use in Canada. Here’s the Flash Briefing I just read on this news.

  https://soundcloud.com/lemsnews/catalyst-still-expecting-firdapse-approval-in-canada-in-2020

   

  Price Wooldridge replied 4 years, 4 months ago 0 Member · 0 Replies

  • Amifampridine
  • Firdapse
  • LEMS
  • treatment
• 0 Replies

Log In to Reply